Tag: "hodgkin" at biology news

FLT PET assesses treatment response on tumor growthnot sizewith non-Hodgkin's lymphoma

SAN DIEGO, Calif.--Positron emission tomography (PET)--with the radiolabeled thymidine analog [18F]Fluorothymidine (FLT)--is "a promising, sensitive tool" for assessing drug effects on tumor growth in patients with diffuse large B-cell lymphoma, according to a study released at SNM's 53rd Annual Meeting June 37 in San Diego.... ... "Conventional imaging modalities--such as computed tomography, ul...

BiovaxID yields 89 percent survival in patients with aggressive non-Hodgkins

Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI) and its subsidiary, Biovest International, Inc. (OTCBB:BVTI), report follow-up data to a Phase 2 trial conducted by the National Cancer Institute (NCI) that shows Biovest's BiovaxID yielded an 89% survival rate in mantle cell lymphoma patients. The median follow-up was 3.8 years. Historically, patients with this type of lymphoma only have had a 50...

PCBs, furans may factor in risk of non-Hodgkin lymphoma

Scientists have found some additional evidence that environmental exposure to polychlorinated biphenyls (PCBs) may be associated with non-Hodgkin lymphoma, according to a study published in the December 1 issue of Cancer Research....... By comparing blood levels of PCBs in 100 pairs of healthy volunteers and non-Hodgkin lymphoma patients, Anneclaire De Roos, Ph.D., assistant professor of epidemio...

Positive effects of nuclear medicine, 'smart drugs' provide hope for non-hodgkin's lymphoma patients

TORONTO, Canada--Three scientific studies--each highlighting new discoveries in treatment for patients with non-Hodgkin's lymphoma--were announced at the Society of Nuclear Medicine's 52nd Annual Meeting June 1822 in Toronto. ...... "Nuclear medicine has a growing role in treating non-Hodgkin's lymphoma," said SNM member Richard L. Wahl, M.D., director of nuclear medicine/PET at the Russell H. Mo...

Hepatitis C virus linked to non-Hodgkin's lymphoma

SEATTLE--Patients infected with the hepatitis C virus (HCV) are six times as likely to develop non-Hodgkin's lymphoma (NHL) than individuals that are virus free, according to research presented today at the Third Annual Frontiers in Cancer Prevention Research meeting.... HCV infected patients have a seventeen fold higher risk for developing diffuse large B-Cell lymphoma, researchers from British...
(Date:10/17/2014)... Copenhagen have shown for the first time how bacteria ... patients, giving them the opportunity to get tremendous insights ... The study also discovered the bacterial growth in chronic ... or slowed down by the immune cells. The researchers ... helped "suffocate" the bacteria, forcing the bacteria to switch ...
(Date:10/16/2014)... on the human body. Battles are won, lost ... cancer, this stalemate—known as tumor dormancy—can last up ... phenomena that is poorly understood. , A ... Salvatore Torquato, a Professor of Chemistry at Princeton ... dormancy and the switch to a malignant state. ...
(Date:10/16/2014)... new synthesis of recent research findings to inform their ... two states. , The Ecology and Management of ... Synthesis of the Relevant Biophysical Science and Implications for ... the U.S. Forest Service,s Pacific Northwest Research Station, is ... a synthesis of the large body of scientific information ...
Breaking Biology News(10 mins):Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2Modeling tumor dormancy 2New report synthesizes best available science on management of moist mixed-conifer forests 2
Other Tags
albatrosseswanderingdarlingmurrayconfirmedstillbirthshaitisyphilisdiabeticsobesebetrayalfearinvestigationaldaytranatolerabilitymonth